The largest database of trusted experimental protocols

5 protocols using pdgf d

1

Colon Cancer Cell-Myofibroblast Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human colon cancer epithelial cells DLD-1 (Male, Dukes’s stage C), HCT116 (Male, Dukes’s stage D), and colonic myofibroblast CCD-18co cells (Female) were obtained from the Korean Cell Line Bank, and SW48 (Female, Dukes’s stage C) was purchased from ATCC. DLD-1 and HCT116 cells were cultured in RPMI-1640 (Gibco, Carlsbad, CA, USA) and CCD-18co and SW48 were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Carlsbad, CA, USA) with L-glutamine (300 mg/L) supplemented with 10% fetal bovine serum (Gibco), penicillin (100 U/mL), and streptomycin (100 μM). DLD-1 cells were treated with TGFβ (R&D systems, Minneapolis, MN, USA), PDGF-D (R&D systems), imatinib (Tocris Bioscience, Bristol, UK), 2-APB (Tocris), and ML-9 (Sigma Aldrich, St. Louis, MO, USA) for 8 or 16 h. The conditioned medium was obtained from the supernatant of cells collected 8 h after PDGF-D stimulation, and treated with fresh medium in a 1:1 ratio to CCD-18co cells. To prevent mycoplasma contamination, Plasmocin™ (Invitrogen, San Diego, CA, USA, ant-mpp) was added to the medium.
+ Open protocol
+ Expand
2

Modulation of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Identifiers for shRNAs used in this study are: V3LHS-644610 (shFRA1#1), V3LHS-644611 (shFRA1#2), V3LHS-320021 (shIGFBP3#1), V2LHS-111629 (shIGFBP3#2) (Dharmacon, GE Lifesciences). IGFBP3 ELISA (Raybiotech) was performed according to the manufacturer’s instructions with 50ug tumour lysate and conditioned media was diluted 1:5. Recombinant proteins were used at the following conditions: 10ng/ml IGF1 (Invitrogen), 10ng/ml EGF (Invitrogen), 10ng/ml PDGFD (R&D Systems), 2μg/ml IGFBP3 (Prospec) for 15min, or 5ug/ml ANGPTL7 (R&D Systems) for 30min.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of PDGF and PDGFR in Paraffin Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histological and immunohistochemical analyses were performed on paraffin sections in which we observed the presence of RN by H&E staining. Each section was immunostained with the following antibodies: PDGF-A (1:20; R&D Systems, USA), PDGF-B (1:20; Abcam, Japan), PDGF-C (1:100; R&D Systems), PDGF-D (1:50; R&D Systems), PDGFR-α (1:20; R&D Systems), and PDGFR-β (1:50; R&D Systems) (Table 2). We routinely use a pressure cooker for 4 minutes to retrieve all the antigens. Endogenous peroxidase was blocked with 0.03% hydrogen peroxide for 40 minutes at room temperature. We used the ABC technique (Vector Laboratories, USA) for all of these antigens, before DAB (3, 3′ diaminobenzidine tetrahydrochloride (Wako Pure Chemical Industries, Japan)). The sections were counterstained with hematoxylin 3G (Sakura Finetek, Japan) and mounted.
+ Open protocol
+ Expand
4

Modulation of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Identifiers for shRNAs used in this study are: V3LHS-644610 (shFRA1#1), V3LHS-644611 (shFRA1#2), V3LHS-320021 (shIGFBP3#1), V2LHS-111629 (shIGFBP3#2) (Dharmacon, GE Lifesciences). IGFBP3 ELISA (Raybiotech) was performed according to the manufacturer’s instructions with 50ug tumour lysate and conditioned media was diluted 1:5. Recombinant proteins were used at the following conditions: 10ng/ml IGF1 (Invitrogen), 10ng/ml EGF (Invitrogen), 10ng/ml PDGFD (R&D Systems), 2μg/ml IGFBP3 (Prospec) for 15min, or 5ug/ml ANGPTL7 (R&D Systems) for 30min.
+ Open protocol
+ Expand
5

Investigating PDGF-D Effects on Brain Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human brain vascular pericytes (HBVP) (ScienCell Research Laboratories, CA, USA; 1200) were used to investigate the molecular mechanisms underlying PDGF-D action. Moreover, immortalized human brain endothelial cells (iHBEC) (Cedarlane Laboratories, ON, Canada; CRL-3245) displaying major BBB features [43 (link), 44 (link)] were used to assess pericyte-endothelial cell interaction. HBVP were cultured at 37 °C in 5% CO2, 95% air in a Dulbecco’s modified Eagle’s medium (DMEM) glucose-normal medium (Multicell; Wisent, QC, Canada) containing 2% fetal bovine serum (FBS), 100 U/mL pericytes growth serum (PGS) and 100 U/mL streptomycin/penicillin. For iHBEC, the surface of flasks/wells was pre-coated with 0.1% gelatin diluted in water (STEMCELL Technologies, BC, Canada) for at least 1 h before iHBEC were seeded. iHBEC were cultured at 37 °C in 5% CO2, 95% air in endothelial cell medium (ECM; ScienCell) containing 2% FBS, 100 U/mL endothelial cell growth serum (ECGS), and 100 U/mL streptomycin/penicillin. In all experiments, cells were grown to 80% confluence and subjected to a maximum of 7 passages. Cells were treated with saline, 40 or 80 ng/mL of PDGF-D (R&D Systems). At the end of each experiment, cell culture medium was collected, and cells were harvested for protein extraction for further analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!